Showing 65,241 - 65,260 results of 70,115 for search '(( 50 ((a decrease) OR (nn decrease)) ) OR ( a ((mean decrease) OR (point decrease)) ))', query time: 1.38s Refine Results
  1. 65241

    Figure 1; Figure 2; Figure 3; Figure 4; Figure 5; Table 1; Table 2; Table 3; Table 4; SupTable 1; SupTable 2; SupTable 3 by Ramachandran Chelliah (3837415)

    Published 2025
    “…</b> <b>Canonical NF-κB activation pathway and its transcriptional role in inflammation-associated bone loss:</b> In resting cells, the NF-κB complex (typically RelA/p50) is sequestered in the cytoplasm by IκBα. …”
  2. 65242

    Image_1_Fermentation weight loss, fermentation quality, and bacterial community of ensiling of sweet sorghum with lactic acid bacteria at different silo densities.pdf by Haiwen Xu (10453244)

    Published 2022
    “…Overall, sweet sorghum silage showed satisfactory fermentation quality, with a density of no <650 kg/m<sup>3</sup>, and inoculating LAB improved fermentation quality and reduced FWL. …”
  3. 65243

    GnRH antagonist impairs the process of embryo implantation by inhibiting motility of endometrial stromal cells through reducing c-kit expression by Jun Tan (46388)

    Published 2024
    “…Moreover, we also found a decreased expression and phosphorylation of c-kit receptor in decidualized hESCs after treating with GnRH-ant. …”
  4. 65244

    Image_2_TGF-β phospho antibody array identifies altered SMAD2, PI3K/AKT/SMAD, and RAC signaling contribute to the pathogenesis of myxomatous mitral valve disease.TIF by Andrew J. McNair (9093310)

    Published 2023
    “…SMAD2 antagonism by siRNA and the SMAD7 agonist asiaticoside decreased detection of pSMAD by at least 50%, significantly decreased expression of the aVIC gene markers ACTA2, TAGLN, and MYH10, and pαSMA, pAKT2, and pERK1, but had no effect on pS6K, pERK2, or pVIM expression in aVICs. …”
  5. 65245

    Table_1_TGF-β phospho antibody array identifies altered SMAD2, PI3K/AKT/SMAD, and RAC signaling contribute to the pathogenesis of myxomatous mitral valve disease.docx by Andrew J. McNair (9093310)

    Published 2023
    “…SMAD2 antagonism by siRNA and the SMAD7 agonist asiaticoside decreased detection of pSMAD by at least 50%, significantly decreased expression of the aVIC gene markers ACTA2, TAGLN, and MYH10, and pαSMA, pAKT2, and pERK1, but had no effect on pS6K, pERK2, or pVIM expression in aVICs. …”
  6. 65246

    Image_3_TGF-β phospho antibody array identifies altered SMAD2, PI3K/AKT/SMAD, and RAC signaling contribute to the pathogenesis of myxomatous mitral valve disease.TIF by Andrew J. McNair (9093310)

    Published 2023
    “…SMAD2 antagonism by siRNA and the SMAD7 agonist asiaticoside decreased detection of pSMAD by at least 50%, significantly decreased expression of the aVIC gene markers ACTA2, TAGLN, and MYH10, and pαSMA, pAKT2, and pERK1, but had no effect on pS6K, pERK2, or pVIM expression in aVICs. …”
  7. 65247

    Data_Sheet_2_TGF-β phospho antibody array identifies altered SMAD2, PI3K/AKT/SMAD, and RAC signaling contribute to the pathogenesis of myxomatous mitral valve disease.docx by Andrew J. McNair (9093310)

    Published 2023
    “…SMAD2 antagonism by siRNA and the SMAD7 agonist asiaticoside decreased detection of pSMAD by at least 50%, significantly decreased expression of the aVIC gene markers ACTA2, TAGLN, and MYH10, and pαSMA, pAKT2, and pERK1, but had no effect on pS6K, pERK2, or pVIM expression in aVICs. …”
  8. 65248

    Image_1_TGF-β phospho antibody array identifies altered SMAD2, PI3K/AKT/SMAD, and RAC signaling contribute to the pathogenesis of myxomatous mitral valve disease.TIF by Andrew J. McNair (9093310)

    Published 2023
    “…SMAD2 antagonism by siRNA and the SMAD7 agonist asiaticoside decreased detection of pSMAD by at least 50%, significantly decreased expression of the aVIC gene markers ACTA2, TAGLN, and MYH10, and pαSMA, pAKT2, and pERK1, but had no effect on pS6K, pERK2, or pVIM expression in aVICs. …”
  9. 65249

    Data_Sheet_1_TGF-β phospho antibody array identifies altered SMAD2, PI3K/AKT/SMAD, and RAC signaling contribute to the pathogenesis of myxomatous mitral valve disease.docx by Andrew J. McNair (9093310)

    Published 2023
    “…SMAD2 antagonism by siRNA and the SMAD7 agonist asiaticoside decreased detection of pSMAD by at least 50%, significantly decreased expression of the aVIC gene markers ACTA2, TAGLN, and MYH10, and pαSMA, pAKT2, and pERK1, but had no effect on pS6K, pERK2, or pVIM expression in aVICs. …”
  10. 65250

    PKM2 is efficiently deleted in mature mSC of mutant mice. by Marie Deck (6829379)

    Published 2022
    “…<p><b>A</b>- Quantitative RT-PCR on sciatic nerve extracts shows decreased PKM1 and increased PKM2 expressions during mSC maturation. …”
  11. 65251

    Data_Sheet_2_Concomitant Immunosuppressive Therapy Use in Eculizumab-Treated Adults With Generalized Myasthenia Gravis During the REGAIN Open-Label Extension Study.pdf by Richard J. Nowak (304244)

    Published 2020
    “…In patients who decreased and/or stopped ≥1 IST, mean daily doses of PRED, AZA, and MMF decreased between OLE baseline and last assessment by 60.8% [standard deviation (SD), 28.07; P < 0.0001], 89.1% (SD, 25.77; P < 0.0001), and 56.0% (SD, 32.99; P < 0.0001), respectively. …”
  12. 65252

    Data_Sheet_1_Concomitant Immunosuppressive Therapy Use in Eculizumab-Treated Adults With Generalized Myasthenia Gravis During the REGAIN Open-Label Extension Study.pdf by Richard J. Nowak (304244)

    Published 2020
    “…In patients who decreased and/or stopped ≥1 IST, mean daily doses of PRED, AZA, and MMF decreased between OLE baseline and last assessment by 60.8% [standard deviation (SD), 28.07; P < 0.0001], 89.1% (SD, 25.77; P < 0.0001), and 56.0% (SD, 32.99; P < 0.0001), respectively. …”
  13. 65253

    Data_Sheet_1_Brief Episodes of Nocturnal Hypoxia and Acidification Reduce Survival of Economically Important Blue Crab (Callinectes sapidus) Larvae.pdf by Stephen J. Tomasetti (6061343)

    Published 2021
    “…Two experiments comparing a diel cycling DO/pH treatment (fluctuating from ∼30% air saturation to ∼103% averaging ∼66%/and from pH ∼7.26 to ∼7.80 averaging ∼7.53) to a static low DO/pH treatment (∼43%/∼7.35), a static moderate DO/pH treatment (∼68%/∼7.59), and a static control treatment (∼106%/∼7.94) indicated that survival in the diel cycling treatment was significantly lower than the moderate treatment (p < 0.05) by 75 and 48% over 96 and 48 h, respectively, despite comparable mean experimental DO/pH values. …”
  14. 65254

    Table1_Acute changes in free and extracellular vesicle-associated circulating miRNAs and myokine profile in professional sky-runners during the Gran Sasso d’Italia vertical run.DOC... by M. Faraldi (13432389)

    Published 2022
    “…Nanoparticle tracking analysis revealed a similar EV size distribution in pre- and post-competition samples and a decreased concentration in post-competition samples related to pre-competition samples. …”
  15. 65255

    Table8_Acute changes in free and extracellular vesicle-associated circulating miRNAs and myokine profile in professional sky-runners during the Gran Sasso d’Italia vertical run.XLS... by M. Faraldi (13432389)

    Published 2022
    “…Nanoparticle tracking analysis revealed a similar EV size distribution in pre- and post-competition samples and a decreased concentration in post-competition samples related to pre-competition samples. …”
  16. 65256

    Data_Sheet_2_Brief Episodes of Nocturnal Hypoxia and Acidification Reduce Survival of Economically Important Blue Crab (Callinectes sapidus) Larvae.xlsx by Stephen J. Tomasetti (6061343)

    Published 2021
    “…Two experiments comparing a diel cycling DO/pH treatment (fluctuating from ∼30% air saturation to ∼103% averaging ∼66%/and from pH ∼7.26 to ∼7.80 averaging ∼7.53) to a static low DO/pH treatment (∼43%/∼7.35), a static moderate DO/pH treatment (∼68%/∼7.59), and a static control treatment (∼106%/∼7.94) indicated that survival in the diel cycling treatment was significantly lower than the moderate treatment (p < 0.05) by 75 and 48% over 96 and 48 h, respectively, despite comparable mean experimental DO/pH values. …”
  17. 65257

    Table7_Acute changes in free and extracellular vesicle-associated circulating miRNAs and myokine profile in professional sky-runners during the Gran Sasso d’Italia vertical run.XLS... by M. Faraldi (13432389)

    Published 2022
    “…Nanoparticle tracking analysis revealed a similar EV size distribution in pre- and post-competition samples and a decreased concentration in post-competition samples related to pre-competition samples. …”
  18. 65258

    Data_Sheet_1_The Association of CSF sTREM2 With Cognitive Decline and Its Dynamic Change in Parkinson's Disease: Analysis of the PPMI Cohort.docx by Qixiong Qin (12882533)

    Published 2022
    “…Additionally, CSF sTREM2 decreased in abnormal Aβ pathology (A+) and α-syn pathology (S+) but normal tau pathology, while increased in abnormal phosphorylated tau (T+) (p < 0.05).…”
  19. 65259

    Table4_Acute changes in free and extracellular vesicle-associated circulating miRNAs and myokine profile in professional sky-runners during the Gran Sasso d’Italia vertical run.XLS... by M. Faraldi (13432389)

    Published 2022
    “…Nanoparticle tracking analysis revealed a similar EV size distribution in pre- and post-competition samples and a decreased concentration in post-competition samples related to pre-competition samples. …”
  20. 65260

    Table2_Acute changes in free and extracellular vesicle-associated circulating miRNAs and myokine profile in professional sky-runners during the Gran Sasso d’Italia vertical run.doc... by M. Faraldi (13432389)

    Published 2022
    “…Nanoparticle tracking analysis revealed a similar EV size distribution in pre- and post-competition samples and a decreased concentration in post-competition samples related to pre-competition samples. …”